TRIB3 mediates glucose-induced insulin resistance via a mechanism that requires the hexosamine biosynthetic pathway

Diabetes

Volumn 62, Issue 12, 2013, Pages 4192-4200

  Zhang, Wei ^a   Liu, Jiarong ^b   Tian, Ling ^a   Liu, Qinglan ^b   Fu, Yuchang ^a   Garvey, W Timothy ^a,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZASERINE; GLUCOSAMINE; GLUCOSE; GLUTAMINE FRUCTOSE 6 PHOSPHATE AMINOTRANSFERASE; HEXOSAMINE; INSULIN; PROTEIN; TRIBBLES HOMOLOG PROTEIN 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE SYNTHESIS; CONTROLLED STUDY; DRUG INDUCED DISEASE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN TREATMENT; MALE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; SKELETAL MUSCLE;

ANIMALS; BIOSYNTHETIC PATHWAYS; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE; HEXOSAMINES; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE; MALE; MUSCLE, SKELETAL; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION;

EID: 84891793531     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-0312     Document Type: Article

References (50)

1. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 1992;15:318-368
2. Hunter SJ, Garvey WT. Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system. Am J Med 1998;105:331-345
3. Garvey WT, Olefsky JM, Griffin J, Hamman RF, Kolterman OG. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes 1985;34:222-234
4. Garvey W, Birnbaum M. Insulin resistance and disease. In Bailliere's clinical endocrinology and metabolism. Ferrannini E, Ed. London, U.K., Bailliere Tindall, 1994, p. 785-873
5. Rossetti L, Giaccari A, DeFronzo RA. Glucose toxicity. Diabetes Care 1990; 13:610-630
6. Unger RH, Grundy S. Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia 1985;28:119-121
7. Friedman JE, Dohm GL, Leggett-Frazier N, et al. Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4. J Clin Invest 1992;89:701-705
8. Greenfield MS, Doberne L, Rosenthal M, Schulz B, Widstrom A, Reaven GM. Effect of sulfonylurea treatment on in vivo insulin secretion and action in patients with non-insulin-dependent diabetes mellitus. Diabetes 1982;31:307-312
9. Kolterman OG, Gray RS, Shapiro G, Scarlett JA, Griffin J, Olefsky JM. The acute and chronic effects of sulfonylurea therapy in type II diabetic subjects. Diabetes 1984;33:346-354
10. Scarlett JA, Kolterman OG, Ciaraldi TP, Kao M, Olefsky JM. Insulin treatment reverses the postreceptor defect in adipocyte 3-O-methylglucose transport in type II diabetes mellitus. J Clin Endocrinol Metab 1983;56:1195-1201
11. Yki-Järvinen H, Helve E, Koivisto VA. Hyperglycemia decreases glucose uptake in type I diabetes. Diabetes 1987;36:892-896
12. Karnieli E, Armoni M, Cohen P, Kanter Y, Rafaeloff R. Reversal of insulin resistance in diabetic rat adipocytes by insulin therapy. Restoration of pool of glucose transporters and enhancement of glucose-transport activity. Diabetes 1987;36:925-931
13. Rossetti L, Smith D, Shulman GI, Papachristou D, DeFronzo RA. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest 1987;79:1510-1515
14. Richter EA, Hansen BF, Hansen SA. Glucose-induced insulin resistance of skeletal-muscle glucose transport and uptake. Biochem J 1988;252:733-737
15. Garvey WT, Olefsky JM, Matthaei S, Marshall S. Glucose and insulin coregulate the glucose transport system in primary cultured adipocytes. A new mechanism of insulin resistance. J Biol Chem 1987;262:189-197
16. Bailey CJ, Turner SL. Glucosamine-induced insulin resistance in L6 muscle cells. Diabetes Obes Metab 2004;6:293-298
17. Baron AD, Zhu JS, Zhu JH, Weldon H, Maianu L, Garvey WT. Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity. J Clin Invest 1995;96: 2792-2801
18. Cooksey RC, Hebert LF Jr, Zhu JH, Wofford P, Garvey WT, McClain DA. Mechanism of hexosamine-induced insulin resistance in transgenic mice overexpressing glutamine:fructose-6-phosphate amidotransferase: decreased glucose transporter GLUT4 translocation and reversal by treatment with thiazolidinedione. Endocrinology 1999;140:1151-1157
19. Marshall S, Bacote V, Traxinger RR. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 1991;266:4706-4712
20. Marshall S. Role of insulin, adipocyte hormones, and nutrient-sensing pathways in regulating fuel metabolism and energy homeostasis: a nutritional perspective of diabetes, obesity, and cancer. Sci STKE 2006; 2006:re7
21. Traxinger RR, Marshall S. Coordinated regulation of glutamine:fructose-6- phosphate amidotransferase activity by insulin, glucose, and glutamine. Role of hexosamine biosynthesis in enzyme regulation. J Biol Chem 1991; 266:10148-10154
22. Marshall S, Bacote V, Traxinger RR. Complete inhibition of glucoseinduced desensitization of the glucose transport system by inhibitors of mRNA synthesis. Evidence for rapid turnover of glutamine:fructose-6-phosphate amidotransferase. J Biol Chem 1991;266:10155-10161
23. Vosseller K, Wells L, Lane MD, Hart GW. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc Natl Acad Sci USA 2002;99:5313-5318
24. Arias EB, Kim J, Cartee GD. Prolonged incubation in PUGNAc results in increased protein O-linked glycosylation and insulin resistance in rat skeletal muscle. Diabetes 2004;53:921-930
25. Wu X, Wang J, Cui X, et al. The effect of insulin on expression of genes and biochemical pathways in human skeletal muscle. Endocrine 2007; 31:5-17
26. Wu X, Patki A, Lara-Castro C, et al. Genes and biochemical pathways in human skeletal muscle affecting resting energy expenditure and fuel partitioning. J Appl Physiol 2011;110:746-755
27. Liu J, Wu X, Franklin JL, et al. Mammalian Tribbles homolog 3 impairs insulin action in skeletal muscle: role in glucose-induced insulin resistance. Am J Physiol Endocrinol Metab 2010;298:E565-E576
28. Liew CW, Bochenski J, Kawamori D, et al. The pseudokinase tribbles homolog 3 interacts with ATF4 to negatively regulate insulin exocytosis in human and mouse beta cells. J Clin Invest 2010;120:2876-2888
29. Prudente S, Sesti G, Pandolfi A, Andreozzi F, Consoli A, Trischitta V. The mammalian tribbles homolog TRIB3, glucose homeostasis, and cardiovascular diseases. Endocr Rev 2012;33:526-546
30. Takahashi Y, Ohoka N, Hayashi H, Sato R. TRB3 suppresses adipocyte differentiation by negatively regulating PPARg transcriptional activity. J Lipid Res 2008;49:880-892
31. Mayor P, Maianu L, Garvey WT. Glucose and insulin chronically regulate insulin action via different mechanisms in BC3H1 myocytes. Effects on glucose transporter gene expression. Diabetes 1992;41:274-285
32. Taylor RP, Parker GJ, Hazel MW, et al. Glucose deprivation stimulates O-GlcNAc modification of proteins through up-regulation of O-linked N-acetylglucosaminyltransferase. J Biol Chem 2008;283:6050-6057
33. Zou L, Zhu-Mauldin X, Marchase RB, et al. Glucose deprivation-induced increase in protein O-GlcNAcylation in cardiomyocytes is calciumdependent. J Biol Chem 2012;287:34419-34431
34. Taylor RP, Geisler TS, Chambers JH, McClain DA. Up-regulation of OGlcNAc transferase with glucose deprivation in HepG2 cells is mediated by decreased hexosamine pathway flux. J Biol Chem 2009;284:3425-3432
35. Liu J, Zhang W, Chuang GC, et al. Role of TRIB3 in regulation of insulin sensitivity and nutrient metabolism during short-term fasting and nutrient excess. Am J Physiol Endocrinol Metab 2012;303:E908-E916
36. Wells L, Vosseller K, Hart GW. Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc. Science 2001;291:2376-2378
37. Yang X, Su K, Roos MD, Chang Q, Paterson AJ, Kudlow JE. O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Proc Natl Acad Sci U S A 2001;98:6611-6616
38. Kamemura K, Hayes BK, Comer FI, Hart GW. Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: alternative glycosylation/phosphorylation of THR-58, a known mutational hot spot of c-Myc in lymphomas, is regulated by mitogens. J Biol Chem 2002;277:19229-19235
39. Gewinner C, Hart G, Zachara N, Cole R, Beisenherz-Huss C, Groner B. The coactivator of transcription CREB-binding protein interacts preferentially with the glycosylated form of Stat5. J Biol Chem 2004;279:3563-3572
40. Gao Y, Miyazaki J, Hart GW. The transcription factor PDX-1 is posttranslationally modified by O-linked N-acetylglucosamine and this modification is correlated with its DNA binding activity and insulin secretion in min6 b-cells. Arch Biochem Biophys 2003;415:155-163
41. Parker GJ, Lund KC, Taylor RP, McClain DA. Insulin resistance of glycogen synthase mediated by O-linked N-acetylglucosamine. J Biol Chem 2003;278:10022-10027
42. Travers MT, Vallance AJ, Gourlay HT, et al. Promoter I of the ovine acetyl-CoA carboxylase-a gene: an E-box motif at-114 in the proximal promoter binds upstream stimulatory factor (USF)-1 and USF-2 and acts as an insulinresponse sequence in differentiating adipocytes. Biochem J 2001;359:273-284
43. Sul HS, Latasa MJ, Moon Y, Kim KH. Regulation of the fatty acid synthase promoter by insulin. J Nutr 2000;130(Suppl.):315S-320S
44. Sander M, Griffen SC, Huang J, German MS. A novel glucose-responsive element in the human insulin gene functions uniquely in primary cultured islets. Proc Natl Acad Sci U S A 1998;95:11572-11577
45. Portois L, Maget B, Tastenoy M, Perret J, Svoboda M. Identification of a glucose response element in the promoter of the rat glucagon receptor gene. J Biol Chem 1999;274:8181-8190
46. Jokela TA, Makkonen KM, Oikari S, et al. Cellular content of UDP-Nacetylhexosamines controls hyaluronan synthase 2 expression and correlates with O-linked N-acetylglucosamine modification of transcription factors YY1 and SP1. J Biol Chem 2011;286:33632-33640
47. McClain DA, Paterson AJ, Roos MD, Wei X, Kudlow JE. Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells. Proc Natl Acad Sci U S A 1992;89:8150-8154
48. Goldberg HJ, Scholey J, Fantus IG. Glucosamine activates the plasminogen activator inhibitor 1 gene promoter through Sp1 DNA binding sites in glomerular mesangial cells. Diabetes 2000;49:863-871
49. Daniel S, Zhang S, DePaoli-Roach AA, Kim KH. Dephosphorylation of Sp1 by protein phosphatase 1 is involved in the glucose-mediated activation of the acetyl-CoA carboxylase gene. J Biol Chem 1996;271:14692-14697
50. Du K, Herzig S, Kulkarni RN, Montminy M. TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 2003;300:1574-1577